Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Phenol in almond oil is a sclerosing agent used for the non-surgical treatment of internal hemorrhoids, specifically second-degree cases. The formulation typically contains 5% phenol, which acts as a chemical irritant. When injected into the submucosal layer at the base of the hemorrhoid (the pedicle), phenol causes protein denaturation and local tissue destruction, triggering an inflammatory response. This process results in fibrosis (scarring) that occludes the small blood vessels and anchors the mucosa to the underlying muscle, effectively shrinking the hemorrhoidal tissue and preventing further prolapse or bleeding. In the study conducted at Gulab Devi Hospital, this treatment was compared against rubber band ligation to evaluate its efficacy and safety profile in adult patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on phenol + almond oil.